Articles

Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma

Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
University of Milan, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
IRIB-CNR, Catanzaro, Italy;
IRIB-CNR, Catanzaro, Italy;
Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute,Boston, USA
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
University of Milan, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy;
Haematologica Early view Feb 20, 2020 https://doi.org/10.3324/haematol.2019.240713